Rossari Biotech Ltd

Rossari Biotech Ltd Share Price Today: Live Updates & Key Insights

Get insights on Rossari Biotech Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Rossari Biotech Ltd Share Price Chart

Rossari Biotech Ltd Fundamentals

Traded Volume: 27,403

Market Cap(Cr): 3,476

Avg Traded Price 875.30

1 Year return -22.65%

Upper Circuit 637

Lower Circuit 625.5

P/E TTM 25.00

P/B Ratio 25.00

Traded Value(Cr) 171.98

EPS TTM 24.669

Book value 24.669

Dividend 0.00%

Rossari Biotech Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Rossari Biotech Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Rossari Biotech Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W -2.43%

1M -1.34%

3M -6.22%

1Y -22.65%

YTD -19.34%

Rossari Biotech Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Rossari Biotech Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 30628.00

Day Before Yesterday 19501.00

1W Avg 21129.75

1M Avg 99408.00

3M Avg 68485.64

Rossari Biotech Ltd Technical Details

Rossari Biotech Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 623

Support 2 619

Support 3 612

Pivot Point : 630

Resistance 1 635

Resistance 2 641

Resistance 3 646

Rossari Biotech Ltd Corporate Actions

Rossari Biotech Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Rossari Biotech Ltd’s capital allocation strategies.

All

Ex-Date 20-Jun-2025 Type D Description 0.50/share@25.00% Record Date 20-Jun-2025 Ratio 25.00

Ex-Date 16-Aug-2024 Type D Description 0.50/share@25.00% Record Date 16-Aug-2024 Ratio 25.00

Ex-Date 24-May-2023 Type D Description 0.50/share@25.00% Record Date 24-May-2023 Ratio 25.00

Ex-Date 07-Jul-2022 Type D Description 0.50/share@25.00% Record Date 08-Jul-2022 Ratio 25.00

Ex-Date 08-Sep-2021 Type D Description 0.50/share@25.00% Record Date 07-Nov-2025 Ratio 25.00

Dividends

Announcement Date 20-Jun-2025 Ex Dividend Date 20-Jun-2025 Dividend(%) 25

Announcement Date 16-Aug-2024 Ex Dividend Date 16-Aug-2024 Dividend(%) 25

Announcement Date 24-May-2023 Ex Dividend Date 24-May-2023 Dividend(%) 25

Announcement Date 07-Jul-2022 Ex Dividend Date 07-Jul-2022 Dividend(%) 25

Announcement Date 08-Sep-2021 Ex Dividend Date 08-Sep-2021 Dividend(%) 25

Bonus

No Bonus has been declared by ROSSARI

Splits

No Split has been declared by ROSSARI

Others

Rights No Rights has been declared by ROSSARI

Rossari Biotech Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Rossari Biotech Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Rossari Biotech Ltd's relative performance and valuation against major competitors.

Stock Name Neogen Chemicals Ltd ₹1452.30 (-0.21%) M. Cap (Cr) 38.31 1 Yr Return (%) -36.82% P/E (TTM) 113.89 PB Ratio 4.85

Stock Name Camlin Fine Sciences Ltd ₹196.01 (+3.54%) M. Cap (Cr) 36.85 1 Yr Return (%) +75.32% P/E (TTM) -32.03 PB Ratio 4.03

Stock Name Tatva Chintan Pharma Chem Ltd ₹1500.20 (+3.28%) M. Cap (Cr) 35.09 1 Yr Return (%) +73.14% P/E (TTM) 197.86 PB Ratio 4.76

Stock Name Rossari Biotech Ltd ₹627.60 (-1.93%) M. Cap (Cr) 34.76 1 Yr Return (%) -22.65% P/E (TTM) 25.44 PB Ratio 2.93

Stock Name Vishnu Chemicals Ltd ₹494.90 (-1.51%) M. Cap (Cr) 33.31 1 Yr Return (%) -10.47% P/E (TTM) 24.06 PB Ratio 3.59

Stock Name Fineotex Chemical Ltd ₹26.36 (+3.58%) M. Cap (Cr) 30.20 1 Yr Return (%) -30.47% P/E (TTM) 28.97 PB Ratio 4.13

Stock Name NOCIL Ltd ₹175.61 (-0.04%) M. Cap (Cr) 29.33 1 Yr Return (%) -38.29% P/E (TTM) 46.51 PB Ratio 1.66

Rossari Biotech Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Rossari Biotech Ltd, across its operating activities, investing activities, and financing activities.

PARTICULARS Operating Activities Mar 2025 92.20 Mar 2024 73.92 Mar 2023 113.66 Mar 2022 33.12 Mar 2021 52.09

PARTICULARS Investing Activities Mar 2025 -69.92 Mar 2024 -69.55 Mar 2023 -160.59 Mar 2022 -318.12 Mar 2021 -37.00

PARTICULARS Financing Activities Mar 2025 -32.27 Mar 2024 -22.09 Mar 2023 61.21 Mar 2022 296.91 Mar 2021 -29.45

PARTICULARS Net Cash Flow Mar 2025 -9.64 Mar 2024 -17.95 Mar 2023 14.28 Mar 2022 11.91 Mar 2021 -14.36

Rossari Biotech Ltd Shareholding Pattern

This shows the ownership breakdown of Rossari Biotech Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter 68.17%

Public 10.95%

Other Institutions 4.91%

FII 2.7%

Mutual Funds 13.27%

About Rossari Biotech Ltd

Rossari Biotech Limited was founded in 2003 as a partnership firm in the name of Rossari Labtech by Mr. Edward Walter Menezes, and Mr. Sunil Srinivasan Chari, who are both career-technocrats cumulatively having over 45 years of experience in the specialty chemicals industry. It was further renamed to Rossari Biotech Limited and converted into a company in 2009. The Company has two state-of-the art facilities at Dahej, Gujarat and Silvassa, Dadra Nagar & Haveli and is mainly engaged in manufacturing, selling and distribution of specialty chemicals. The products cater to global brands in the FMCG sector and find applications in a host of consumer-centric products and home and personal care products, textile chemicals, animal health and nutrition and cosmetic products. During the FY2020, 50,00,000 equity shares of face value of Rs 10 each was sub-divided into 2,50,00,000 Equity Shares of face value of Rs 2 each. Accordingly 4,400,000 paid-up equity shares of face value of Rs 10 each was split into 22,000,000 Equity Shares of face value of Rs 2 each.The Company has issued and allotted 2,64,00,000 Equity Shares of face value of Rs 2/- each to the eligible Members of the Company in the ratio of 6(Six) Equity share for every 5 (Five) Equity shares, as Bonus Equity shares. During the year 2019-20, in compliance with the provisions of Sections 42 & 62 of the Act and Rules made thereunder, the Company has issued and allotted 23,52,920 Equity Shares of face value of Rs 2/- each to the eligible Qualified Institutional Buyers at issue price of Rs 425/- per Equity Share i.e. at a premium of Rs 423/- per Equity Share aggregating to Rs 99,99,91,000 /-on preferential basis through private placement.During the second quarter of FY2021,the Company has completed Initial Public Offer (IPO) of 11,676,470 Equity Shares of the face value of Rs. 2/- each at an issue price of Rs. 425/- per Equity Share, comprising offer for sale of 10,500,000 shares by Selling Shareholders and fresh issue of 1,176,470 shares. The Equity Shares of the Company were listed on 23 July 2020 on Bombay Stock Exchange and National Stock Exchange of India Limited.The Company has a wholly owned subsidiary, Rossari Personal Care Products Private Limited (Formerly known as Neutron Impex Private Limited) which was engaged in the business of manufacturing, exporting and importing specialty chemicals, dyes, etc. upto 31 March 2015. The Company has also acquired a Joint Venture (JV) company, Buzil Rossari Private Limited, engaged in the business of providing Trading of specialty chemicals. Buzil Rossari Private Limited (BRPL) became a wholly owned subsidiary of the Company w.e.f. 31 August 2020.During the year ended on 31 March, 2021, the Board of Directors at its meeting held on 23 March, 2021, has approved the issue of 3,012,046 equity shares on preferential basis for cash consideration . Subsequent to year ended 31March, 2021, the shareholders of the Company at its Extra Ordinary General meeting held on 17April, 2021 has approved issue of 3,012,046 shares of face value of Rs. 2 each on preferential basis at price of Rs. 996 per share aggregating to Rs. 3000.00 million. The allotment of the shares of the Company has been completed on 21April, 2021.Pursuant to the lockdowns by the central and state government authorities to contain the spread of COVID-19 outbreak, the Company's operations and financial results for the year have been impacted. The operations gradually resumed in a phased manner with requisite precautions during the year ended 31 March, 2021. Company achieved the full commissioning of its Greenfield manufacturing facility at Dahej, Gujarat on 31st March, 2021.During the quarter ended 30 June, 2021, the Company at the meeting of the Board of Directors held on 02 June, 2021 has agreed to acquire 100% of shareholding of Unitop Chemicals Private Limited at an aggregate consideration of Rs. 4,210 million from the existing shareholders in multiple tranches, subject to completion of the customary terms and conditions.Also Subsequent to the quarter ended 30 June, 2021, the Company at the meeting of the Board of Directors held on 17 July, 2021 has agreed to acquire 100% shareholding of Tristar Intermediates Private Limited at an aggregate consideration of Rs. 1,200.00 million from the existing shareholders in multiple tranches, subject to completion of the customary terms and conditions.Further, subsequent to quarter ended 30 June, 2021, the Company at its meeting of the Board of Directors held on 30 July 2021 has resolved to make a strategic investment by acquiring and/or subscribing to equity shares equivalent to 50.10% of the issued and paid-up share capital of Romakk Chemicals Private Limited (Romakk) at an aggregate consideration of Rs. 75.10 million.Subsequent to the quarter ended 30 June 2021, the Company has acquired balance 40% stake in its subsidiary Rossari Personal Care Products Private Limited for aggregate consideration of Rs. 20.00 million making it a wholly owned subsidiary of the Company.Solar Panel was Installed at Dahej Plant to accommodate 1 MW Solar Power Installation in FY'22. Total Energy Savings in FY21-22 was 50 KVA. During the Financial Year 2021-22, the Company announced strategic acquisitions of three high-quality and high potential companies in the Speciality Chemical space viz. Unitop Chemicals Private Limited, Tristar Intermediates Private Limited, and Romakk Chemicals Private Limited. Strategic investment in Unitop Chemicals, Tristar Intermediates and Romakk Chemicals unlocked significant cross selling opportunities. A new line of products based on polyester chemistry was developed and ramped up at Rossari's Dahej facility, addressing a key product gap in textile portfolio for the sizing of market in polyester and cotton fabric. R&D introduced green products in newer divisions to reduce high TDS and save energy by designing products that work at lower temperatures. The `Sustainable dyeing', programmed for blacks, using Green Chemistry, has been successful on knit fabric and is generating good interest from big brands. During 2021-22, the Company acquired a controlling stake in Unitop Chemicals. It acquired Tristar Intermediates, aroma chemicals, and home and personal care additives with high-tech distillation facilities. It completed the integration of Romakk Chemicals during FY'22, acquiring a 50.1% stake in the company. During FY 2022-23, the Company acquired additional stake of 15% in Unitop Chemicals Pvt Ltd (UCPL) and 8% in Tristar Intermediates Pvt Ltd., taking the Company's holding to 80% and 84%, respectively. Also, the Company has acquired the remaining 16% stake in TIPL after the end of the Financial Year 2022-23.The Company acquired the balance 16% stake in its subsidiary, Tristar Intermediates, during the year 2024. The Company expanded the Dahej Facility by 20,000 MTPA. The ethoxylation capacity increased doubled in FY 24. It launched Spin finish products for synthetic and regenerated fibers in FY 2025. It has started groundwork for entry into coating chemicals for technical textiles and silicone wax lubricants.

Managing Director

Sunil Chari

Registered office 201 A-B 2nd Floor LBS Marg, Akruti Corporate Park Kanjur(W, Mumbai, Maharashtra, 400079

FAX :91-22-6123 3800

Background

Incorporation Year 2009

Face Value ₹2.00

Market Lot 1

Rossari Biotech Ltd Latest News

VIEW MORE NEWS

FAQs on Rossari Biotech Ltd